The Impact of Chronic Disease Management Program (Prolanis) to Improve The Clinical Outcome of Patients Diabetes Mellitus Type 2: A Study in Primary Health Care Center In Jakarta, Indonesia
Abstract
Prolanis is a Chronic Disease Management Program under the Indonesian National Health Insurance for promoting and preventing chronic disease. Main activities of Prolanis program are disease control and counseling, scheduled education, scheduled exercise, participant’s remainder, and home visit. The aim of this study was to evaluate the impact of prolanis on the clinical outcome in type 2 Diabetes Mellitus (DM) patients. An observational retrospective study was evaluated for 12 months. Data was collected from medical record. 426 patients from five primary health care center in Jakarta was selected by simple random sampling and divided into prolanis and non-prolanis groups. The indicators were the difference of clinical outcome between prolanis and non-prolanis patients was analyzed using Mann-Whitney test; the correlation of adherence with clinical outcome was analyzed using Chi-Square test.The results showed that prolanis patients had a significant improvement in Fasting Blood Glucose (FBG) compared with non-prolanis patients (P<0.05). The adherence of prolanis patients showed a significant improvement on FBG (124 patients-58.2%). Patients with nonadherence had lower improvement on FBG, the improvement was observed only at 16 patients (7.5%) and 60 patients (28.17%) was poor FBG. Prolanis is an effective program to improve the clinical outcome of DM patients.
References
Program). Jakarta: Badan Pelaksana Jaminan Sosial Kesehatan; 2014. h. 5–15.
2. Perkumpulan Endokrinologi Indonesia (PERKENI). Consensus on the Management and Prevention of Type
2 Diabetes Mellitus in Indonesia. Jakarta: PB Perkeni; 2011. h. 1, 4, 6-7, 20-21, 23, 26, 28, 47-48.
3. Dinaryanti P, Fudholi A, Andayani TM. Cost Analysis and Effectiveness of Therapy for Outpatient Type 2
Diabetes Mellitus Patients in Sleman Yogyakarta Hospital. Yogyakarta: Jurnal Manajemen dan Pelayanan
Farmasi. 2012;2(1).
4. Kementrian Kesehatan Republik Indonesia. Basic Health Research. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2013. h. 89.
5. Asti, T. Patient Compliance: Important Factors in Succesful Therapy. Info POM. 2006;7(5).
6. Shaqina I. The Relation of Participation in the National Health Insurance Program (JKN) with Medical Compliance with Patients with Type 2 Diabetes Mellitus at Simpur Bandar Lampung Health Center. Lampung:
Fakultas Kedokteran Universitas Lampung; 2016.
7. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: Switzerland;
2003. h. 5, 72, 75-76.
8. Delamater, Alan. Improving Patient Adherence. American Diabetes Association. 2006;24(72).
9. Notoatmodjo, S. Public Health Sciences: Basic Principles. Jakarta: Rineka Cipta; 2003.
10. Anggriani Y, Restinia M, Kusumaeni T, Meryta A. Treatment Profi le of Type 2 Diabetes Mellitus Outpatients
After National Health Insurance Implementation. Jurnal Ilmu Kefarmasian Indonesia. 2015; 13 (ISSN
1693-1831):2.
11. Muflikhatin, S. K. & Fakhrudin. Relationship Between Age, Hereditary History And Diet With Type 2
Diabetes Mellitus In The Flamboyant Room Hospital Abdul Wahab Sjahranie Samarinda. e-jurnal STIKES
Muhammadiyah Samarinda 3. 2015; 1–14
12. Trisnawati KS, Setyorogo S. Risk Factors for the Occurrence of Type II Diabetes Mellitus in the Cengkareng
West Jakarta District Health Center in 2012. Jurnal Ilmiah Kesehatan. 2013;5(1):6-11.
13. Hannan, M. Analysis of Factors Aff ecting Compliance with Medication in Diabetes Mellitus Patients in Bluto
Sumenep Health Center. J. Kesehat. Wiraraja Med. 2013; 47–55.
14. Subagiyo, R. A. Relationship between the Level of Compliance with Medication and Blood Glucose Levels
in Diabetes Mellitus Patients at Anisah Demak Clinic. 2018; 508–514.
15. Departemen Kesehatan Republik Indonesia. Pharmaceutical Care For Diabetes Mellitus. Jakarta: Direktorat
Bina Farmasi Komunitas dan Klinik Ditjen Bina Kefarmasian dan Alat Kesehatan; 2006.
16. Putri NH, Isfandiari MA. Relationship of the Four Pillars of Control of Type 2 DM with Average Blood Sugar Levels. Jurnal Berkala Epidemiologi. 2013;1(2).
17. Donald E Morisky, A. A. M. K.-W. and H. J. W. Predictive Validity of A Medication Adherence Measure
in an Outpatient Setting. J. Clin. Hypertens. 10. 2008; 348–354.
18. Badan Pelaksana Jaminan Sosial Kesehatan. Guideline Practice of Prolanis (Chronic Disease Management
Program). Jakarta: Badan Pelaksana Jaminan Sosial Kesehatan. 2014; 5–15.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Tools
